https://www.livemint.com/market/stock-market-news/lupin-share-price-up-39-in-last-one-year-can-it-rise-more-should-you-buy-lupin-stock-11687413398683.html
0
0
6/22/23 at 6:02am
Organization
Livemint
Author
Nishant Kumar
Lupin received approval from the US FDA for its abbreviated new drug application for generic Spiriva HandiHaler. The drug is expected to add between $80m and $100m to Lupin's annual sales by FY24/25.
Create an account
or login to join the discussion